Table 5. Comparison between VDRL and TPHA titers in late syphilis patients with and without HIV.
Late Syphilis |
VDRL |
TPHA |
||
HIV (+) |
HIV (-) |
HIV (+) |
HIV (-) |
|
Baseline |
||||
Mean ± SD |
1:63 ± 1:97 |
1:16 ± 1:31 |
1:2507 ± 1:2,165 |
1:2,795 ± 1:4,990 |
Median (range) |
1:24 (1:2-1:256) |
1:8 (1:2-1:128) |
1:1,920 (1:320-5,120) |
1:1,280 (1:80-1:20,480) |
p-value |
0.134 |
0.455 |
||
1 Month Follow-Up After Therapy |
||||
Mean ± SD |
1:24 ± 1:31 |
1:10 ± 1:17 |
1:1056 ± 1:862 |
1:3,680 ± 1:6,685 |
Median (range) |
1:4 (1:2-1:64) |
1:4 (0-1:64) |
1:960 (1:256-2,560) |
1:1,280 (0-1:20,480) |
p-value |
0.257 |
0.707 |
||
Last Follow-Up After Therapy |
||||
Mean ± SD |
1:105 ± 1:200 |
1:8 ± 1:11 |
1:9,440 ± 1:15,861 |
3,600 ± 1:6,719 |
Median (range) |
1:24 (1:4-1:512) |
1:2 (0-1:32) |
1:1,920 (1:320-1:40,960) |
1:960 (0-1:20,480) |
p-value |
0.017 |
0.193 |